Targeting intratumoral heterogeneity in TNBC with novel combinations of FDA-approved drugs

被引：0
|
作者：
Truchan, Nathan A. [1 ]
Burnett, Joseph P. [1 ]
Sun, Duxin [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-968
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
968
引用
收藏
页数：2
相关论文
共 50 条
  • [21] An analysis of FDA-approved drugs for neurological disorders
    Kinch, Michael S.
    DRUG DISCOVERY TODAY, 2015, 20 (09) : 1040 - 1043
  • [22] A systematic analysis of FDA-approved anticancer drugs
    Sun, Jingchun
    Wei, Qiang
    Zhou, Yubo
    Wang, Jingqi
    Liu, Qi
    Xu, Hua
    BMC SYSTEMS BIOLOGY, 2017, 11 : 27 - 43
  • [23] FDA-APPROVED DRUGS TO TREAT SLEEP DISORDERS
    不详
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2018, 56 (10)
  • [24] Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus
    Sharma, Amar Deep
    Gutheil, William G.
    MICROBIOLOGY SPECTRUM, 2023, 11 (01):
  • [25] Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi
    Planer, Joseph D.
    Hulverson, Matthew A.
    Arif, Jennifer A.
    Ranade, Ranae M.
    Don, Robert
    Buckner, Frederick S.
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (07):
  • [26] Targeting the β-clamp in Helicobacter pylori with FDA-approved drugs reveals micromolar inhibition by diflunisal
    Pandey, Preeti
    Verma, Vijay
    Gautam, Gunjan
    Kumari, Nilima
    Dhar, Suman Kumar
    Gourinath, Samudrala
    FEBS LETTERS, 2017, 591 (15): : 2311 - 2322
  • [27] Screening of an FDA-Approved Library for Novel Drugs against Y. pestis
    Gur, David
    Chitlaru, Theodor
    Mamroud, Emanuelle
    Zauberman, Ayelet
    ANTIBIOTICS-BASEL, 2021, 10 (01): : 1 - 8
  • [28] Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles
    Sara Tucker Edmister
    Thaís Del Rosario Hernández
    Rahma Ibrahim
    Cameron A. Brown
    Sayali V. Gore
    Rohit Kakodkar
    Jill A. Kreiling
    Robbert Creton
    Scientific Reports, 12
  • [29] Novel use of FDA-approved drugs identified by cluster analysis of behavioral profiles
    Edmister, Sara Tucker
    Hernandez, Thais Del Rosario
    Ibrahim, Rahma
    Brown, Cameron A.
    Gore, Sayali, V
    Kakodkar, Rohit
    Kreiling, Jill A.
    Creton, Robbert
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [30] Identification of FDA-approved drugs as novel allosteric inhibitors of human executioner caspases
    Deepak, R. N. V. Krishna
    Abdullah, Ahmad
    Talwar, Priti
    Fan, Hao
    Ravanan, Palaniyandi
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2018, 86 (11) : 1202 - 1210
12345